BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

279 related articles for article (PubMed ID: 26168919)

  • 21. Is mass drug administration against lymphatic filariasis required in urban settings? The experience in Kano, Nigeria.
    Pam DD; de Souza DK; D'Souza S; Opoku M; Sanda S; Nazaradden I; Anagbogu IN; Okoronkwo C; Davies E; Elhassan E; Molyneux DH; Bockarie MJ; Koudou BG
    PLoS Negl Trop Dis; 2017 Oct; 11(10):e0006004. PubMed ID: 29020042
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Evaluation of lymphatic filariasis in endemic area of Brazil where mass drug administration is not required.
    Silva E; Xavier A; Silva E; Barbosa Júnior W; Rocha A; Freitas V; Oliveira P; Aguiar-Santos AM; Bonfim C; Medeiros Z
    Pathog Glob Health; 2019 May; 113(3):143-148. PubMed ID: 31138026
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A surveillance system for lymphatic filariasis after its elimination in Sri Lanka.
    Rahman MA; Yahathugoda TC; Tojo B; Premaratne P; Nagaoka F; Takagi H; Kannathasan S; Murugananthan A; Weerasooriya MV; Itoh M
    Parasitol Int; 2019 Feb; 68(1):73-78. PubMed ID: 30308253
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The impact of residual infections on Anopheles-transmitted Wuchereria bancrofti after multiple rounds of mass drug administration.
    de Souza DK; Ansumana R; Sessay S; Conteh A; Koudou B; Rebollo MP; Koroma J; Boakye DA; Bockarie MJ
    Parasit Vectors; 2015 Sep; 8():488. PubMed ID: 26399968
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Comparison of the Impact of Annual and Semiannual Mass Drug Administration on Lymphatic Filariasis Prevalence in Flores Island, Indonesia.
    Supali T; Djuardi Y; Lomiga A; Nur Linda S; Iskandar E; Goss CW; Miller JP; Weil GJ; Fischer PU
    Am J Trop Med Hyg; 2019 Feb; 100(2):336-343. PubMed ID: 30560772
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Evidence for stopping mass drug administration for lymphatic filariasis in some, but not all local government areas of Plateau and Nasarawa States, Nigeria.
    King JD; Eigege A; Umaru J; Jip N; Miri E; Jiya J; Alphonsus KM; Sambo Y; Graves P; Richards F
    Am J Trop Med Hyg; 2012 Aug; 87(2):272-80. PubMed ID: 22855758
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The impact of four years of semiannual treatments with albendazole alone on lymphatic filariasis and soil-transmitted helminth infections: A community-based study in the Democratic Republic of the Congo.
    Pion SDS; Chesnais CB; Awaca-Uvon NP; Vlaminck J; Abdou A; Kunyu-Shako B; Kuyangisa Simuna G; Tambwe JP; Weil GJ; Boussinesq M
    PLoS Negl Trop Dis; 2020 Jun; 14(6):e0008322. PubMed ID: 32574160
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Human infection with Wuchereria bancrofti in Matara, Sri Lanka: the use, in parallel, of an ELISA to detect filaria-specific IgG4 in urine and of ICT card tests to detect filarial antigen in whole blood.
    Weerasooriya MV; Itoh M; Mudalige MP; Qiu XG; Kimura E; Gunawardena NK; Fujimaki Y
    Ann Trop Med Parasitol; 2003 Mar; 97(2):179-85. PubMed ID: 12803873
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Mapping lymphatic filariasis in Loa loa endemic health districts naïve for ivermectin mass administration and situated in the forested zone of Cameroon.
    Beng AA; Esum ME; Deribe K; Njouendou AJ; Ndongmo PWC; Abong RA; Fru J; Fombad FF; Nchanji GT; Amambo G; Gandjui NTV; Biholong B; Nko'Ayissi G; Mbia P; Akame J; Enyong PI; Reid SD; Tougoue JJ; Zhang Y; Wanji S
    BMC Infect Dis; 2020 Apr; 20(1):284. PubMed ID: 32299374
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Effect of annual mass administration of diethylcarbamazine and albendazole on bancroftian filariasis in five villages in south India.
    Ramaiah KD; Vanamail P; Yuvaraj J; Das PK
    Trans R Soc Trop Med Hyg; 2011 Aug; 105(8):431-7. PubMed ID: 21601901
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Mapping of lymphatic filariasis in loiasis areas: A new strategy shows no evidence for Wuchereria bancrofti endemicity in Cameroon.
    Wanji S; Esum ME; Njouendou AJ; Mbeng AA; Chounna Ndongmo PW; Abong RA; Fru J; Fombad FF; Nchanji GT; Ngongeh G; Ngandjui NV; Enyong PI; Storey H; Curtis KC; Fischer K; Fauver JR; Lew D; Goss CW; Fischer PU
    PLoS Negl Trop Dis; 2019 Mar; 13(3):e0007192. PubMed ID: 30849120
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The effect of compliance on the impact of mass drug administration for elimination of lymphatic filariasis in Egypt.
    El-Setouhy M; Abd Elaziz KM; Helmy H; Farid HA; Kamal HA; Ramzy RM; Shannon WD; Weil GJ
    Am J Trop Med Hyg; 2007 Dec; 77(6):1069-73. PubMed ID: 18165524
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Effect of yearly mass drug administration with diethylcarbamazine and albendazole on bancroftian filariasis in Egypt: a comprehensive assessment.
    Ramzy RM; El Setouhy M; Helmy H; Ahmed ES; Abd Elaziz KM; Farid HA; Shannon WD; Weil GJ
    Lancet; 2006 Mar; 367(9515):992-9. PubMed ID: 16564361
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Changes in Wuchereria bancrofti infection in a highly endemic community following 10 rounds of mass administration of diethylcarbamazine.
    Ramaiah KD; Vanamail P; Das PK
    Trans R Soc Trop Med Hyg; 2007 Mar; 101(3):250-5. PubMed ID: 16890256
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Imported bancroftian filariasis: diethylcarbamazine response and benzimidazole susceptibility of Wuchereria bancrofti in dynamic cross-border migrant population targeted by the National Program to Eliminate Lymphatic Filariasis in South Thailand.
    Bhumiratana A; Pechgit P; Koyadun S; Siriaut C; Yongyuth P
    Acta Trop; 2010 Feb; 113(2):121-8. PubMed ID: 19835831
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Dynamics of antigenemia and transmission intensity of Wuchereria bancrofti following cessation of mass drug administration in a formerly highly endemic region of Mali.
    Coulibaly YI; Coulibaly SY; Dolo H; Konate S; Diallo AA; Doumbia SS; Soumaoro L; Coulibaly ME; Dicko I; Sangare MB; Dembele B; Sangare M; Dembele M; Touré YT; Kelly-Hope L; Polman K; Kyelem D; Traore SF; Bockarie M; Klion AD; Nutman TB
    Parasit Vectors; 2016 Dec; 9(1):628. PubMed ID: 27912789
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Border and imported bancroftian filariases: baseline seroprevalence in sentinel populations exposed to infections with Wuchereria bancrofti and concomitant HIV at the start of diethylcarbamazine mass treatment in Thailand.
    Bhumiratana A; Koyadun S; Srisuphanunt M; Satitvipawee P; Limpairojn N; Gaewchaiyo G
    Southeast Asian J Trop Med Public Health; 2005 Mar; 36(2):390-407. PubMed ID: 15916046
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Wuchereria bancrofti infection in rural tropical guinea savannah communities: Rapid epidemiological assessment using immunochromatographic card test and prevalence of hydrocoele.
    Ivoke N; Ezeabikwa BO; Ivoke ON; Ekeh FN; Ezenwaji NE; Odo GE; Onoja US; Eyo JE
    Trop Biomed; 2015 Jun; 32(2):365-75. PubMed ID: 26691265
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Distribution of filarial elephantiasis and hydrocele in Matara district, Sri Lanka, as reported by local leaders, and an immunological survey in areas with relatively high clinical rates.
    Weerasooriya MV; Isogai Y; Itoh M; Yahathugoda TC; Vidanapathirana KK; Mudalige MP; Kimura E
    Parasitol Int; 2008 Sep; 57(3):390-5. PubMed ID: 18508407
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Comparison of antigen and antibody responses in repeat lymphatic filariasis transmission assessment surveys in American Samoa.
    Won KY; Robinson K; Hamlin KL; Tufa J; Seespesara M; Wiegand RE; Gass K; Kubofcik J; Nutman TB; Lammie PJ; Fuimaono S
    PLoS Negl Trop Dis; 2018 Mar; 12(3):e0006347. PubMed ID: 29522520
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.